Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dicerna Pharma (DRNA)
NASDAQ:DRNA
Holding DRNA?
Track your performance easily
See the Price Targets and Ratings of:
DRNA Analyst Ratings
Hold
1 Buy
7 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DRNA Stock 12 Month Forecast
Average Price Target
$36.01
▼(-5.78% Downside)
| Highest Price Target$38.30 | Average Price Target$36.01 | Lowest Price Target$23.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Evercore ISI
Reiterated
08/06/21
DRNA Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
DRNA Financial Forecast
DRNA Stock Forecast FAQ
What is DRNA’s average 12-month price target, according to analysts?
Based on analyst ratings, Dicerna Pharma’s 12-month average price target is $36.01.
What is DRNA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DRNA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DRNA a Buy, Sell or Hold?
Dicerna Pharma has a consensus rating of Hold which is based on 1 buy ratings, 7 hold ratings and 0 sell ratings.
What is Dicerna Pharma’s price target?
The average price target for Dicerna Pharma is $36.01. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $38.30 ,the lowest forecast is $23.00. The average price target represents -5.78% Decrease from the current price of $38.22.
The highest analyst price target is $38.30 ,the lowest forecast is $23.00. The average price target represents -5.78% Decrease from the current price of $38.22.
What do analysts say about Dicerna Pharma?
Dicerna Pharma’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of DRNA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.